Cargando…
Supramolecular Hydrogel Based Post-Surgical Implant System for Hydrophobic Drug Delivery Against Glioma Recurrence
PURPOSE: The brain, protected by the cranium externally and the blood–brain barrier (BBB) internally, poses challenges in chemotherapy of aggressive brain tumors. Maximal tumor resection followed by radiation and chemotherapy is the standard treatment protocol; however, a substantial number of patie...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122075/ https://www.ncbi.nlm.nih.gov/pubmed/35599751 http://dx.doi.org/10.2147/IJN.S348559 |
_version_ | 1784711271012106240 |
---|---|
author | Wanjale, Mrunal Vitthal Sunil Jaikumar, Vishnu Sivakumar, K C Ann Paul, Riya James, Jackson Kumar, G S Vinod |
author_facet | Wanjale, Mrunal Vitthal Sunil Jaikumar, Vishnu Sivakumar, K C Ann Paul, Riya James, Jackson Kumar, G S Vinod |
author_sort | Wanjale, Mrunal Vitthal |
collection | PubMed |
description | PURPOSE: The brain, protected by the cranium externally and the blood–brain barrier (BBB) internally, poses challenges in chemotherapy of aggressive brain tumors. Maximal tumor resection followed by radiation and chemotherapy is the standard treatment protocol; however, a substantial number of patients suffer from recurrence. Systemic circulation of drugs causes myelodysplasia and other side effects. To address these caveats, we report facile synthesis of a polyester-based supramolecular hydrogel as a brain biocompatible implant for in situ delivery of hydrophobic drugs. METHODS: Polycaprolactone-diol (PCL) was linked to polyethyleneglycol-diacid (PEG) via an ester bond. In silico modeling indicated micelle-based aggregation of PCL-PEG co-polymer to form a supramolecular hydrogel. Brain biocompatibility was checked in Sprague Dawley rat brain cortex with MRI, motor function test, and histology. Model hydrophobic drugs carmustine and curcumin entrapment propelled glioma cells into apoptosis-based death evaluated by in vitro cytotoxicity assays and Western blot. In vivo post-surgical xenograft glioma model was developed in NOD-SCID mice and evaluated for efficacy to restrict aggressive regrowth of tumors. RESULTS: 20% (w/v) PCL-PEG forms a soft hydrogel that can cover the uneven and large surface area of a tumor resection cavity and maintain brain density. The PCL-PEG hydrogel was biocompatible, and well-tolerated upon implantation in rat brain cortex, for a study period of 12 weeks. We report for the first time the combination of carmustine and curcumin entrapped as model hydrophobic drugs, increasing their bioavailability and yielding synergistic apoptotic effect on glioma cells. Further in vivo study indicated PCL-PEG hydrogel with a dual cargo of carmustine and curcumin restricted aggressive regrowth post-resection significantly compared with control and animals with intravenous drug treatment. CONCLUSION: PCL-PEG soft gel-based implant is malleable compared with rigid wafers used as implants, thus providing larger surface area contact. This stable, biocompatible, supramolecular gel without external crosslinking can find wide applications by interchanging formulation of various hydrophobic drugs to ensure and increase site-specific delivery, avoiding systemic circulation. |
format | Online Article Text |
id | pubmed-9122075 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-91220752022-05-21 Supramolecular Hydrogel Based Post-Surgical Implant System for Hydrophobic Drug Delivery Against Glioma Recurrence Wanjale, Mrunal Vitthal Sunil Jaikumar, Vishnu Sivakumar, K C Ann Paul, Riya James, Jackson Kumar, G S Vinod Int J Nanomedicine Original Research PURPOSE: The brain, protected by the cranium externally and the blood–brain barrier (BBB) internally, poses challenges in chemotherapy of aggressive brain tumors. Maximal tumor resection followed by radiation and chemotherapy is the standard treatment protocol; however, a substantial number of patients suffer from recurrence. Systemic circulation of drugs causes myelodysplasia and other side effects. To address these caveats, we report facile synthesis of a polyester-based supramolecular hydrogel as a brain biocompatible implant for in situ delivery of hydrophobic drugs. METHODS: Polycaprolactone-diol (PCL) was linked to polyethyleneglycol-diacid (PEG) via an ester bond. In silico modeling indicated micelle-based aggregation of PCL-PEG co-polymer to form a supramolecular hydrogel. Brain biocompatibility was checked in Sprague Dawley rat brain cortex with MRI, motor function test, and histology. Model hydrophobic drugs carmustine and curcumin entrapment propelled glioma cells into apoptosis-based death evaluated by in vitro cytotoxicity assays and Western blot. In vivo post-surgical xenograft glioma model was developed in NOD-SCID mice and evaluated for efficacy to restrict aggressive regrowth of tumors. RESULTS: 20% (w/v) PCL-PEG forms a soft hydrogel that can cover the uneven and large surface area of a tumor resection cavity and maintain brain density. The PCL-PEG hydrogel was biocompatible, and well-tolerated upon implantation in rat brain cortex, for a study period of 12 weeks. We report for the first time the combination of carmustine and curcumin entrapped as model hydrophobic drugs, increasing their bioavailability and yielding synergistic apoptotic effect on glioma cells. Further in vivo study indicated PCL-PEG hydrogel with a dual cargo of carmustine and curcumin restricted aggressive regrowth post-resection significantly compared with control and animals with intravenous drug treatment. CONCLUSION: PCL-PEG soft gel-based implant is malleable compared with rigid wafers used as implants, thus providing larger surface area contact. This stable, biocompatible, supramolecular gel without external crosslinking can find wide applications by interchanging formulation of various hydrophobic drugs to ensure and increase site-specific delivery, avoiding systemic circulation. Dove 2022-05-16 /pmc/articles/PMC9122075/ /pubmed/35599751 http://dx.doi.org/10.2147/IJN.S348559 Text en © 2022 Wanjale et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Wanjale, Mrunal Vitthal Sunil Jaikumar, Vishnu Sivakumar, K C Ann Paul, Riya James, Jackson Kumar, G S Vinod Supramolecular Hydrogel Based Post-Surgical Implant System for Hydrophobic Drug Delivery Against Glioma Recurrence |
title | Supramolecular Hydrogel Based Post-Surgical Implant System for Hydrophobic Drug Delivery Against Glioma Recurrence |
title_full | Supramolecular Hydrogel Based Post-Surgical Implant System for Hydrophobic Drug Delivery Against Glioma Recurrence |
title_fullStr | Supramolecular Hydrogel Based Post-Surgical Implant System for Hydrophobic Drug Delivery Against Glioma Recurrence |
title_full_unstemmed | Supramolecular Hydrogel Based Post-Surgical Implant System for Hydrophobic Drug Delivery Against Glioma Recurrence |
title_short | Supramolecular Hydrogel Based Post-Surgical Implant System for Hydrophobic Drug Delivery Against Glioma Recurrence |
title_sort | supramolecular hydrogel based post-surgical implant system for hydrophobic drug delivery against glioma recurrence |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122075/ https://www.ncbi.nlm.nih.gov/pubmed/35599751 http://dx.doi.org/10.2147/IJN.S348559 |
work_keys_str_mv | AT wanjalemrunalvitthal supramolecularhydrogelbasedpostsurgicalimplantsystemforhydrophobicdrugdeliveryagainstgliomarecurrence AT suniljaikumarvishnu supramolecularhydrogelbasedpostsurgicalimplantsystemforhydrophobicdrugdeliveryagainstgliomarecurrence AT sivakumarkc supramolecularhydrogelbasedpostsurgicalimplantsystemforhydrophobicdrugdeliveryagainstgliomarecurrence AT annpaulriya supramolecularhydrogelbasedpostsurgicalimplantsystemforhydrophobicdrugdeliveryagainstgliomarecurrence AT jamesjackson supramolecularhydrogelbasedpostsurgicalimplantsystemforhydrophobicdrugdeliveryagainstgliomarecurrence AT kumargsvinod supramolecularhydrogelbasedpostsurgicalimplantsystemforhydrophobicdrugdeliveryagainstgliomarecurrence |